Baycol/Lipobay: a prescription for trial
Author: Angelmar, Reinhard INSEAD Area: MarketingPublisher: Fontainebleau : INSEAD, 2006.Language: EnglishDescription: 26 p.Type of document: INSEAD CaseNote: Latest version available via https://publishing.insead.eduAbstract: Initially available only in low doses, sales of the aggressively priced Baycol/Lipobay anticholesterol drug pick up when the product is marketed at higher doses, especially in the large US market. On course for 1 billion sales, the product is withdrawn worldwide in response to reports of a number of deaths associated with its use. The withdrawal results in public criticism of the pharmaceutical industry and Bayer, many lawsuits against Bayer, and a decline in the sales and profitability of its pharmaceutical division.Pedagogical Objectives: The case can be used to discuss: . the role of product safety for industry and company reputation, and the legal and financial consequences of product liability issues . risk management: identifying and managing product safety associated risks . the tradeoffs between product and financial performance and safety risks.| Item type | Current location | Collection | Call number | Status | Date due | Barcode | Item holds |
|---|---|---|---|---|---|---|---|
|
Asia Campus Archives | Consultation only | BC007636 | ||||
|
|
Europe Campus INSEAD Publications Display | Consultation only | BC007635 |
Latest version available via <a href=https://publishing.insead.edu>https://publishing.insead.edu</a>
The case can be used to discuss:
. the role of product safety for industry and company reputation, and the legal and financial consequences of product liability issues
. risk management: identifying and managing product safety associated risks
. the tradeoffs between product and financial performance and safety risks.
Initially available only in low doses, sales of the aggressively priced Baycol/Lipobay anticholesterol drug pick up when the product is marketed at higher doses, especially in the large US market. On course for 1 billion sales, the product is withdrawn worldwide in response to reports of a number of deaths associated with its use. The withdrawal results in public criticism of the pharmaceutical industry and Bayer, many lawsuits against Bayer, and a decline in the sales and profitability of its pharmaceutical division.
There are no comments for this item.